Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial

Carl J. Fichtenbaum(Cancer Research And Biostatistics), Dushyantha Jayaweera(University of Miami), Aimee Wilkin(Wake Forest University), Adrián Curran(Lexington City Schools), Heather J. Ribaudo(Cancer Research And Biostatistics), Sue Siminski(Frontier Science & Technology Research Foundation, Inc.), Daniel J. Skiest(Baystate Medical Center), Desirée V G dos Santos, Edgar T. Overton(University of Alabama at Birmingham), David Mushatt(Tulane University), Breno Santos(Hospital Nossa Senhora da Conceição), Ana Gonzalez‐Cordón, Armando Paez, Beverly E. Sha(Rush University Medical Center), Craig A. Sponseller, Cristina Gómez‐Ayerbe(Instituto Ramón y Cajal de Investigación Sanitaria), David Rial‐Crestelo, Udo Hoffmann(Duke Medical Center), Yvetot Joseph(Gheskio Centers), Janet Lo(Harvard University), Alexandra Abrams-Downey(Icahn School of Medicine at Mount Sinai), Jorge Leon-Cruz(Harvard University), Pamela S. Douglas(Duke University), Charlotte-Paige Rolle, Allison Ross Eckard(Medical University of South Carolina), Steven Grinspoon(Massachusetts General Hospital), Patrice Desvigne‐Nickens(National Heart Lung and Blood Institute), Kathleen Melbourne(Gilead Sciences (United States)), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Gerald S. Bloomfield, Emma M. Kileel(Boston University), Judith S. Currier(University of California, Los Angeles), Kathleen V. Fitch(Harvard University), Charurut Somboonwit, Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Deborah K Perez, C. Funk, Daniel E. Nixon(Virginia Commonwealth University), Cynthia Frank, Markella V. Zanni(Harvard University)
The Journal of Infectious Diseases
May 12, 2020
Cited by 13


Related Papers